1. Home
  2. GTY vs ZLAB Comparison

GTY vs ZLAB Comparison

Compare GTY & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GTY

Getty Realty Corporation

HOLD

Current Price

$36.09

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$20.20

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTY
ZLAB
Founded
1955
2013
Country
United States
China
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
GTY
ZLAB
Price
$36.09
$20.20
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$32.60
$49.60
AVG Volume (30 Days)
533.0K
851.8K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
5.92%
N/A
EPS Growth
8.00
38.46
EPS
0.43
N/A
Revenue
$221,727,000.00
$460,156,000.00
Revenue This Year
$9.39
$9.75
Revenue Next Year
$7.83
$26.03
P/E Ratio
$83.93
N/A
Revenue Growth
9.02
15.33
52 Week Low
$25.39
$15.96
52 Week High
$36.12
$41.20

Technical Indicators

Market Signals
Indicator
GTY
ZLAB
Relative Strength Index (RSI) 73.33 58.40
Support Level $32.41 $16.84
Resistance Level N/A $21.12
Average True Range (ATR) 0.58 0.82
MACD 0.18 0.16
Stochastic Oscillator 87.54 76.19

Price Performance

Historical Comparison
GTY
ZLAB

About GTY Getty Realty Corporation

Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: